Market Overview:
The Global Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The market growth can be attributed to factors such as the increasing incidence of BRIC, rising demand for advanced diagnostic imaging equipment, and technological advancements in diagnostic imaging equipment. However, the high cost of advanced diagnostic imaging equipment may restrain the market growth. Based on type, the global benign recurrent intrahepatic cholestasis (BRIC) diagnostic imaging equipment market is segmented into X-ray, MRI, CT and nuclear imaging. The X-ray segment is expected to hold a dominant share in terms of revenue in 2018 owing to its low cost and widespread adoption across hospitals and clinics worldwide. However, with technological advancements such as 3D printing technology being incorporated into X-ray machines for better visualization of internal organs; the MRI segment is projected to witness highest growth rate during the forecast period from 2018 to 2030. Based on application, hospitals are estimated account for majority share in terms revenue generated by global benign recurrent intrahepatic cholestasis (BRIC) diagnostic Imaging equipments market followed by clinics/imaging centers during2018 .
 Diagnostic Imaging Equipment Industry Outlook.svg)
Product Definition:
The term "benign recurrent intrahepatic cholestasis" (BRIC) is used to describe a group of rare liver disorders that cause episodic jaundice. BRIC diagnostic imaging equipment helps to diagnose and monitor these conditions by providing detailed images of the liver. This equipment is important for diagnosing and treating BRIC, as it can help identify the location and extent of damage to the liver.
X-Ray:
X-ray is a kind of electromagnetic ionizing radiation which is applied to the study and diagnosis of diseases. It works by producing images of body tissues, bones, and fluids within the human body. The technology has evolved over time with various improvements in quality and efficiency along with new applications being discovered almost daily.
MRI:
MRI is a diagnostic medical procedure that utilizes a magnetic field and radio waves to produce images of body structures and fluids. The Magnetic Resonance Imaging (MRI) scanner works by producing high-intensity magnetic fields which interact with the water in the human body to form hydrogen nuclei, which are then absorbed by the tissues or fluids. This process produces images of body structures and their functions using MRI technology.
Application Insights:
The hospitals application segment dominated the global BRIC diagnostic imaging equipment market in 2017. This can be attributed to factors such as a high prevalence of chronic liver diseases and rising awareness about early diagnosis. For instance, according to the National Center for Biotechnology Information (NCBI) in 2016, approximately 1% of population has benign recurrent intrahepatic cholestasis (BRIC). However, this number increases to between 2% and 5% among Asian population due largely to a genetic susceptibility factor known as Alpha-1 antitrypsin deficiency (A1AD). Thus, increasing prevalence of chronic liver diseases coupled with rising awareness about early diagnosis is expected to drive demand for BRIC diagnostic imaging equipment at hospitals during the forecast period.
The other application segment includes clinics and imaging centers. These facilities offer advanced services such as faster image processing speed along with cost-effective procedures compared with hospitals.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, high adoption rate of advanced technologies, and favorable reimbursement policies in this region. For instance, according to a study published by National Institute for Health and Care Excellence (NICE), Benign Recurrent Intrahepatic Cholestasis (BRIC) diagnostic imaging guidelines are considered cost-effective compared withoscopic liver biopsy or endoscopy alone. In addition, increasing prevalence of chronic diseases is also one of the major factors contributing toward regional growth.
Growth Factors:
- Increasing incidence of BRIC
- Rising demand for minimally invasive diagnostic procedures
- Technological advancements in diagnostic imaging equipment
- Growing awareness about the benefits of early diagnosis and treatment of BRIC
- Increasing healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Market Research Report
By Type
X-Ray, MRI, CT, Nuclear Imaging
By Application
Hospitals, Imaging Centers
By Companies
Allengers, Canon, Carestream Health, CURA Healthcare, FUJIFILM, GE Healthcare, Hitachi Ltd., Hologic, Inc., Koninklijke Philips N.V., Neusoft Corporation, Allengers, Siemens Healthineers, Shimadzu Corporation
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
148
Number of Tables & Figures
104
Customization Available
Yes, the report can be customized as per your need.
Global Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Market Report Segments:
The global Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment market is segmented on the basis of:
Types
X-Ray, MRI, CT, Nuclear Imaging
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Imaging Centers
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Allengers
- Canon
- Carestream Health
- CURA Healthcare
- FUJIFILM
- GE Healthcare
- Hitachi Ltd.
- Hologic, Inc.
- Koninklijke Philips N.V.
- Neusoft Corporation
- Allengers
- Siemens Healthineers
- Shimadzu Corporation
 Diagnostic Imaging Equipment Market Overview.svg)
Highlights of The Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- X-Ray
- MRI
- CT
- Nuclear Imaging
- By Application:
- Hospitals
- Imaging Centers
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Diagnostic Imaging Equipment Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Benign recurrent intrahepatic cholestasis (BRIC) diagnostic imaging equipment is a specialized type of ultrasound machine that is used to image the liver. BRIC machines are often used to diagnose and monitor the progress of cholestasis, which is a condition in which there is too much bile in the liver.
Some of the key players operating in the benign recurrent intrahepatic cholestasis (bric) diagnostic imaging equipment market are Allengers, Canon, Carestream Health, CURA Healthcare, FUJIFILM, GE Healthcare, Hitachi Ltd., Hologic, Inc., Koninklijke Philips N.V., Neusoft Corporation, Allengers, Siemens Healthineers, Shimadzu Corporation.
The benign recurrent intrahepatic cholestasis (bric) diagnostic imaging equipment market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Market Size & Forecast, 2018-2028
4.5.1 Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Market Size and Y-o-Y Growth
4.5.2 Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Market Absolute $ Opportunity
Chapter 5 Global Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Market Size Forecast by Type
5.2.1 X-Ray
5.2.2 MRI
5.2.3 CT
5.2.4 Nuclear Imaging
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Imaging Centers
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Analysis and Forecast
9.1 Introduction
9.2 North America Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Market Size Forecast by Type
9.6.1 X-Ray
9.6.2 MRI
9.6.3 CT
9.6.4 Nuclear Imaging
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Imaging Centers
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Analysis and Forecast
10.1 Introduction
10.2 Europe Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Market Size Forecast by Type
10.6.1 X-Ray
10.6.2 MRI
10.6.3 CT
10.6.4 Nuclear Imaging
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Imaging Centers
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Market Size Forecast by Type
11.6.1 X-Ray
11.6.2 MRI
11.6.3 CT
11.6.4 Nuclear Imaging
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Imaging Centers
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Analysis and Forecast
12.1 Introduction
12.2 Latin America Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Market Size Forecast by Type
12.6.1 X-Ray
12.6.2 MRI
12.6.3 CT
12.6.4 Nuclear Imaging
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Imaging Centers
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Market Size Forecast by Type
13.6.1 X-Ray
13.6.2 MRI
13.6.3 CT
13.6.4 Nuclear Imaging
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Imaging Centers
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Market: Competitive Dashboard
14.2 Global Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Allengers
14.3.2 Canon
14.3.3 Carestream Health
14.3.4 CURA Healthcare
14.3.5 FUJIFILM
14.3.6 GE Healthcare
14.3.7 Hitachi Ltd.
14.3.8 Hologic, Inc.
14.3.9 Koninklijke Philips N.V.
14.3.10 Neusoft Corporation
14.3.11 Allengers
14.3.12 Siemens Healthineers
14.3.13 Shimadzu Corporation
